P573 Safety and immune modulatory properties of etrasimod (APD334), a next-generation oral, selective sphingosine 1-phosphate receptor (S1PR) modulator, in healthy volunteers
Year: 2018
Type: conference-abstract
Source: Journal of Crohn s and Colitis
Authors: L Peyrin-Biroulet, J Adams, S Turner, L Trokan, J Panes
Institutions: Inserm, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine, Arena Pharmaceuticals (United States), Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2791816688